ITEM VIEW

Should health care money in South Africa be spent on drotrecogin alfa?

dc.contributor.authorTaylor B
dc.contributor.authorBurns D
dc.contributor.authorVan de Wal BW
dc.contributor.authorMBewu T
dc.contributor.authorKeeton GR
dc.date.accessioned2013-01-23T13:47:14Z
dc.date.available2013-01-23T13:47:14Z
dc.date.issued2003
dc.identifier.citationSouth African Medical Journal
dc.identifier.urihttp://hdl.handle.net/10019.1/77556
dc.descriptionGesondheidswetenskappe
dc.descriptionInterne Geneeskunde
dc.descriptionPlease help us populate SUNScholar with the post print version of this article. It can be e-mailed to: scholar@sun.ac.za
dc.publisherROUTLEDGE TAYLOR & FRANCIS LTD, 4 PARK SQUARE, MILTON PARK, ABINGDON, ENGLAND, OXFORDSHIRE, OX14 4RN
dc.titleShould health care money in South Africa be spent on drotrecogin alfa?
dc.typeJournal Articles (subsidised)


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

ITEM VIEW